2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl]
![2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl] Structure](https://image.chemsrc.com/caspic/166/913253-56-2.png)
2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl] structure
|
Common Name | 2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N-[2-(dimethylamino)ethyl] | ||
|---|---|---|---|---|
| CAS Number | 913253-56-2 | Molecular Weight | 328.39100 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H20N6O3S | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
|
Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders.
J. Lipid Res. 49 , 1855-1862, (2008) Quantification of pristanic acid, phytanic acid, and very long chain fatty acids (i.e., hexacosanoic, tetracosanoic, and docosanoic acids) in plasma is the primary method for investigateing a multitude of peroxisomal disorders (PDs). Typically based on GC-MS,... |
|
|
Synthesis of benzofurazan derivatization reagents for carboxylic acids and its application to analysis of fatty acids in rat plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry.
Biomed. Chromatogr. 19 , 802-808, (2005) The derivatization regents for carboxylic acids, DAABD-AE (4-[2-(N,N-dimethylamino)ethylaminosulfonyl]7-(2-aminoethylamino)-2,1,3-benzoxadiazole), MePZBD-AE ([4-(4-N-methyl)piperazinosulfonyl]-7-(2-aminoethylamino)-2,1,3-benzoxadiazole) and APZBD-NHMe ([4-(4-... |
Journals:
More...